Latest News
Via MarketBeat · March 5, 2026

The average American has multiple credit cards. Here's what's actually normal in 2026 and how many you really need.
Via The Motley Fool · March 5, 2026
Here's how investors can prepare for potential volatility.
Via The Motley Fool · March 5, 2026
Lumen has been hit with some big sell-offs recently, but it's still up 45% over the last year.
Via The Motley Fool · March 5, 2026
Logitech International (NASDAQ:LOGI) Passes Key Peter Lynch GARP Investment Filterschartmill.com
Via Chartmill · March 5, 2026

The rent still has to be paid, regardless of the direction of tariffs.
Via The Motley Fool · March 5, 2026
Nearly half of Americans are making the same quiet money mistake every month. Here's what it is and how to fix it.
Via The Motley Fool · March 5, 2026
Will the coin's woes accelerate or melt away?
Via The Motley Fool · March 5, 2026
These monthly dividend stocks expect 2026 to be even better than last year.
Via The Motley Fool · March 5, 2026
NetEase Inc. ADR (NASDAQ:NTES) Emerges as a Prime Value Investing Candidatechartmill.com
Via Chartmill · March 5, 2026
Via Talk Markets · March 5, 2026
Via Talk Markets · March 5, 2026
If you're concerned about keeping your Social Security benefits, here's what you need to know.
Via The Motley Fool · March 5, 2026
While a rotation toward value has already happened, I believe ignoring tech stocks is a mistake.
Via The Motley Fool · March 5, 2026
One of Bitcoin's biggest believers is buying the dip, but history suggests more downside might be coming.
Via The Motley Fool · March 5, 2026
Dorman Products Inc (NASDAQ:DORM) Passes Key Peter Lynch GARP Screener Testschartmill.com
Via Chartmill · March 5, 2026
Via Talk Markets · March 5, 2026
One has a nearly $2 billion backlog. The other is building an entirely new business model from orbit.
Via The Motley Fool · March 5, 2026
If it sounds too good to be true, it probably is.
Via The Motley Fool · March 5, 2026
By the mid-1950s, studies of large groups of people linked smoking with lung cancer. But Dr. Oscar Auerbach still had work to do.
Via Investor's Business Daily · March 5, 2026
Two analysts have big concerns about these stocks.
Via The Motley Fool · March 5, 2026
Palladyne AI reported a loss of $0.04 per share, down from a loss of $1.75 per share during the same quarter a year ago, and better than Wall Street’s expectations of a loss of $0.14 per share.
Via Stocktwits · March 5, 2026